Next-generation molecular sequencing
81455 (81445 for Medicare to change to 81479)
Different cancer types
Gastrointestinal stromal tumor (GIST)
Non-Small-Cell Lung Cancer (NSCLC)
FFPE tissue block preferred. Unstained slides accepted.
Block is preferred, or send 10 unbaked, positively charged, unstained slides cut at 5 µm.
If submitting a sample for both the OmniSeq Comprehensive Assay and the Immune Report Card Assay, see the Immune Report Card Assay test menu page for complete specimen requirements.
Primary tumor type and stage of disease required. Please include the pathology report when submitting a sample. If a pathology report is not received with the sample, testing will be delayed.
Causes for Rejection
Tumor block containing insufficient tumor; broken or stained slides; decalcified bone biopsies; cytology smears. Specimens with very small amounts of tumor and/or less than requested number of slides will be accepted with the caveat that complete testing may not be possible.
FFPE blocks are stored at room temperature and shipped with no special precautions, except when daily outside temperatures exceed 35°C, and then ship with cool packs to avoid paraffin meltdown.
The assay measures all types of relevant mutations (SNVs, CNV, fusions) for a comprehensive assessment of the tumor.
OmniSeq Comprehensive is a next-generation molecular sequencing assay that tests tumor DNA and RNA, identifying somatic variants in 144 genes.